NEPHROS INC·4

Jan 9, 4:30 PM ET

Harris Joseph Michael 4

4 · NEPHROS INC · Filed Jan 9, 2023

Insider Transaction Report

Form 4
Period: 2023-01-05
Transactions
  • Award

    Common Stock

    2023-01-05+8,4028,402 total
  • Award

    Stock Option (right to buy)

    2023-01-05+7,0807,080 total
    Exercise: $1.07Exp: 2033-01-05Common Stock (7,080 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $1.25Exp: 2032-09-06Common Stock (13,115 underlying)
    13,115
Footnotes (3)
  • [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date.
  • [F2]This option vests as to 4,372 shares on each of 9/6/22 and 9/6/23 and as to 4,371 shares on 9/6/24.
  • [F3]Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES